These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 32102248)

  • 21. Emerging Role of Vitamins D and K in Modulating Uremic Vascular Calcification: The Aspect of Passive Calcification.
    Hou YC; Lu CL; Zheng CM; Chen RM; Lin YF; Liu WC; Yen TH; Chen R; Lu KC
    Nutrients; 2019 Jan; 11(1):. PubMed ID: 30642029
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The matrix-gla protein awakening may lead to the demise of vascular calcification].
    Delanaye P; Liabeuf S; Bouquegneau A; Cavalier É; Massy ZA
    Nephrol Ther; 2015 Jul; 11(4):191-200. PubMed ID: 25794931
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vitamin K Status, Warfarin Use, and Arterial Stiffness in Heart Failure.
    Hashmath Z; Lee J; Gaddam S; Ansari B; Oldland G; Javaid K; Mustafa A; Vasim I; Akers S; Chirinos JA
    Hypertension; 2019 Feb; 73(2):364-370. PubMed ID: 30580682
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Desphospho-Uncarboxylated Matrix-Gla Protein Is Increased Postoperatively in Cardiovascular Risk Patients.
    Dahlberg S; Ede J; Schurgers L; Vermeer C; Kander T; Klarin B; Schött U
    Nutrients; 2018 Jan; 10(1):. PubMed ID: 29303985
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Role of Matrix Gla Protein (MGP) in Vascular Calcification.
    Bjørklund G; Svanberg E; Dadar M; Card DJ; Chirumbolo S; Harrington DJ; Aaseth J
    Curr Med Chem; 2020; 27(10):1647-1660. PubMed ID: 30009696
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibit progression of coronary artery calcification with vitamin K in hemodialysis patients (the iPACK-HD study): a randomized, placebo-controlled multi-center, pilot trial.
    Holden RM; Booth SL; Zimmerman D; Moist L; Norman PA; Day AG; Menard A; Fu X; Shea MK; Babiolakis CS; Nolan R; Turner ME; Ward E; Kaufmann M; Adams MA; Heyland DK
    Nephrol Dial Transplant; 2023 Feb; 38(3):746-756. PubMed ID: 35641194
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The abnormal status of uncarboxylated matrix Gla protein species represents an additional mortality risk in heart failure patients with vascular disease.
    Mayer O; Seidlerová J; Vaněk J; Karnosová P; Bruthans J; Filipovský J; Wohlfahrt P; Cífková R; Windrichová J; Knapen MH; Drummen NE; Vermeer C
    Int J Cardiol; 2016 Jan; 203():916-22. PubMed ID: 26618253
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vitamin K deficiency: the linking pin between COPD and cardiovascular diseases?
    Piscaer I; Wouters EFM; Vermeer C; Janssens W; Franssen FME; Janssen R
    Respir Res; 2017 Nov; 18(1):189. PubMed ID: 29132356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular Calcification in Chronic Kidney Disease: The Role of Vitamin K- Dependent Matrix Gla Protein.
    Roumeliotis S; Dounousi E; Salmas M; Eleftheriadis T; Liakopoulos V
    Front Med (Lausanne); 2020; 7():154. PubMed ID: 32391368
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Menaquinone-7 Supplementation to Reduce Vascular Calcification in Patients with Coronary Artery Disease: Rationale and Study Protocol (VitaK-CAC Trial).
    Vossen LM; Schurgers LJ; van Varik BJ; Kietselaer BL; Vermeer C; Meeder JG; Rahel BM; van Cauteren YJ; Hoffland GA; Rennenberg RJ; Reesink KD; de Leeuw PW; Kroon AA
    Nutrients; 2015 Oct; 7(11):8905-15. PubMed ID: 26516910
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel conformation-specific antibodies against matrix gamma-carboxyglutamic acid (Gla) protein: undercarboxylated matrix Gla protein as marker for vascular calcification.
    Schurgers LJ; Teunissen KJ; Knapen MH; Kwaijtaal M; van Diest R; Appels A; Reutelingsperger CP; Cleutjens JP; Vermeer C
    Arterioscler Thromb Vasc Biol; 2005 Aug; 25(8):1629-33. PubMed ID: 15961706
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vitamin K Supplementation for Prevention of Vascular Calcification in Chronic Kidney Disease Patients: Are We There Yet?
    Roumeliotis S; Duni A; Vaios V; Kitsos A; Liakopoulos V; Dounousi E
    Nutrients; 2022 Feb; 14(5):. PubMed ID: 35267901
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin K status and mortality after kidney transplantation: a cohort study.
    Keyzer CA; Vermeer C; Joosten MM; Knapen MH; Drummen NE; Navis G; Bakker SJ; de Borst MH
    Am J Kidney Dis; 2015 Mar; 65(3):474-83. PubMed ID: 25453995
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inflammation-mediated vitamin K and vitamin D effects on vascular calcifications in people with HIV on active antiretroviral therapy.
    Janus SE; Durieux JC; Hajjari J; Carneiro H; McComsey GA
    AIDS; 2022 Apr; 36(5):647-655. PubMed ID: 34907958
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vitamin K-Dependent Carboxylation of Matrix Gla Protein Influences the Risk of Calciphylaxis.
    Nigwekar SU; Bloch DB; Nazarian RM; Vermeer C; Booth SL; Xu D; Thadhani RI; Malhotra R
    J Am Soc Nephrol; 2017 Jun; 28(6):1717-1722. PubMed ID: 28049648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of vitamin K status and rationale for vitamin K supplementation in dialysis patients.
    Caluwé R; Verbeke F; De Vriese AS
    Nephrol Dial Transplant; 2020 Jan; 35(1):23-33. PubMed ID: 30590803
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Circulating Dephospho-Uncarboxylated Matrix Gla-Protein Is Associated With Kidney Dysfunction and Arterial Stiffness.
    Puzantian H; Akers SR; Oldland G; Javaid K; Miller R; Ge Y; Ansari B; Lee J; Suri A; Hasmath Z; Townsend R; Chirinos JA
    Am J Hypertens; 2018 Aug; 31(9):988-994. PubMed ID: 29788226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extrahepatic Vitamin K-Dependent Gla-Proteins-Potential Cardiometabolic Biomarkers.
    Galunska B; Yotov Y; Nikolova M; Angelov A
    Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542487
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of desphospho-uncarboxylated matrix gla protein with incident cardiovascular disease and all-cause mortality: Results from the prospective Bruneck Study.
    Willeit K; Santer P; Tschiderer L; Pechlaner R; Vermeer C; Willeit J; Kiechl S
    Atherosclerosis; 2022 Jul; 353():20-27. PubMed ID: 35764030
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Circulating nonphosphorylated carboxylated matrix gla protein predicts survival in ESRD.
    Schlieper G; Westenfeld R; Krüger T; Cranenburg EC; Magdeleyns EJ; Brandenburg VM; Djuric Z; Damjanovic T; Ketteler M; Vermeer C; Dimkovic N; Floege J; Schurgers LJ
    J Am Soc Nephrol; 2011 Feb; 22(2):387-95. PubMed ID: 21289218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.